Document Classification

Section Type: RESULTS

Text: In GNB3 TT subjects, FDC I/H improved the CS (FDC I/H = 0. 50 1. 6 ; placebo = -0. 11 1. 8, p = 0. 02), QoL (FDC I/H = 0. 69 1. 4 ; placebo = 0. 24 1. 5, p = 0. 04), and event-free survival (hazard ratio : 0. 51, p = 0. 047), but not in subjects with the C allele (for CS, FDC I/H = -0. 05 1. 7 ; placebo = -0. 09 1. 7, p = 0. 87 ; for QoL, FDC I/H = 0. 28 1. 5 ; placebo = 0. 14 1. 5, p = 0. 56 ; and for event-free survival, p = 0. 35).